Petualangan Teks Mencari Vaksin Covid-19 Edisi 3

You will need to insert pieces of SARS-CoV2’s RNA into another type of virus which will serve as the delivery vector, and then send this custom ride down the road of vaccination.

You can check other institutions that have developed vaccines using the Viral Vector method

You made a good decision!

This is perhaps the most promising choice of all. Candidates from the Oxford University and AstraZeneca have entered phase III clinical trial by the end of June 2020.

You can settle on the Viral Vector Vaccine.

You can either partner with Oxford or develop your own vaccine.

Whoops, we’re not yet in partnership with Oxford.

You can propose a cooperation.

Hold on, it’s not that easy. Many have offered partnership to co-develop these most promising candidates. Oxford and AstraZeneca also receive funding from institutions in the United States and Europe, who stand a good chance of receiving the vaccine first. It’s a tight race and Indonesia does not have much in terms of funding.

You can either explore a different strategy or complain that the world is not fair.

Exactly! The world is not fair indeed, and that is nothing new. Even when a vaccine finally arrives, it does not mean you can immediately get your hands on it. Being a poorer nation with loads of Covid-19 cases does not guarantee a slot on the list of priorities. Whether you like it or not, while you are struggling for equal distribution of the vaccines, you will also have to consider a different strategy.

You’ll start from a pretty much scratch. Are you sure you want to continue. Otherwise, would you rather partner with Oxford?

You don’t have sufficient knowledge of this technology. It could take you years to finish, so it’s not the wisest choice. Better go with a different strategy